In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.

Nat Med · 2022 · PMC9018416 · PMID 35347281

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Compared with placebo, B-VEC-treated wounds demonstrated a numerical trend of shorter time to wound closure and longer wound closure duration.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.